Allianz Asset Management Gmb H Acadia Pharmaceuticals Inc Transaction History

Allianz Asset Management Gmb H

$70.3 Billion
Q1 2025

A detailed history of Allianz Asset Management Gmb H transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 33,600 shares of ACAD stock, worth $717,024. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,600

Previous 38,600 12.95%

Holding current value

$717,024

Previous $708,000 21.19%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$16.61 - $20.29 $83,050 - $101,450	-5,000 Reduced 12.95%	33,600 $558,000
Q4 2024 Feb 03, 2025	BUY	$14.29 - $18.76 $151,474 - $198,856	10,600 Added 37.86%	38,600 $708,000
Q3 2024 Nov 12, 2024	BUY	$15.14 - $19.14 $423,920 - $535,920	28,000 New	28,000 $430,000
Q4 2023 Feb 12, 2024	BUY	$20.78 - $31.77 $132,992 - $203,328	6,400 New	6,400 $200,000
Q2 2022 Aug 12, 2022	BUY	$13.01 - $27.22 $170,496 - $356,718	13,105 Added 37.34%	48,205 $679,000
Q4 2021 Feb 11, 2022	BUY	$16.79 - $27.09 $589,329 - $950,859	35,100 New	35,100 $820,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $2.08 Million - $2.94 Million	-107,185 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$25.02 - $54.99 $3.46 Million - $7.61 Million	-138,388 Reduced 56.35%	107,185 $2.77 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $5.9 Million - $8.17 Million	-143,804 Reduced 36.93%	245,573 $13.1 Million
Q3 2020 Nov 13, 2020	SELL	$36.42 - $57.0 $955,842 - $1.5 Million	-26,245 Reduced 6.31%	389,377 $16.1 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $5.37 Million - $7.22 Million	136,895 Added 49.11%	415,622 $20.1 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $1.86 Million - $2.75 Million	58,760 Added 26.71%	278,727 $11.8 Million
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $5.91 Million - $8.39 Million	163,138 Added 287.07%	219,967 $9.41 Million
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $88 - $176	-4 Reduced 0.01%	56,829 $2.06 Million
Q2 2019 Aug 08, 2019	SELL	$23.32 - $28.12 $101,698 - $122,631	-4,361 Reduced 7.13%	56,833 $1.52 Million
Q1 2019 May 13, 2019	BUY	$16.17 - $27.38 $112,009 - $189,661	6,927 Added 12.76%	61,194 $1.64 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $777,103 - $1.24 Million	54,267 New	54,267 $870,000
Q2 2018 Aug 13, 2018	SELL	$15.07 - $22.34 $420,528 - $623,397	-27,905 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$26.84 - $39.14 $30,812 - $44,932	-1,148 Reduced 3.95%	27,905 $840,000
Q3 2017 Nov 13, 2017	SELL	$29.49 - $38.37 $2,506 - $3,261	-85 Reduced 0.29%	29,053 $1.1 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-36,195 Reduced 55.4%	29,138 $835,000
Q1 2017 Apr 17, 2019	BUY	N/A	5,345 Added 8.91%	65,333 $2.24 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-6,204 Reduced 9.37%	59,988 $1.73 Million
Q3 2016 Apr 17, 2019	BUY	N/A	66,192	66,192 $2.16 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

165M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.45B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Acadia Pharmaceuticals Inc Transaction History